6-Mar-2026
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
Globe Newswire (Tue, 3-Mar 8:00 AM ET)
Business Wire (Mon, 2-Mar 12:39 PM ET)
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Globe Newswire (Wed, 11-Feb 4:02 PM ET)
Globe Newswire (Thu, 5-Feb 10:48 AM ET)
Kuehn Law Encourages Investors of Inspire Medical Systems, Inc. to Contact Law Firm
PRNewswire (Fri, 30-Jan 1:59 PM ET)
Business Wire (Thu, 22-Jan 3:36 PM ET)
Impulse Dynamics Announces New Chief Financial Officer
Globe Newswire (Tue, 13-Jan 9:00 AM ET)
Globe Newswire (Mon, 12-Jan 6:45 AM ET)
Globe Newswire (Wed, 7-Jan 8:00 AM ET)
Rosen Law Urges Inspire Medical Investors to Act Ahead of Key Class Action Deadline
Market Chameleon (Tue, 25-Nov 6:08 AM ET)
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Inspire Medical Systems trades on the NYSE stock market under the symbol INSP.
As of March 6, 2026, INSP stock price climbed to $62.99 with 1,125,012 million shares trading.
INSP has a beta of 0.77, meaning it tends to be less sensitive to market movements. INSP has a correlation of 0.03 to the broad based SPY ETF.
INSP has a market cap of $1.80 billion. This is considered a Small Cap stock.
Last quarter Inspire Medical Systems reported $269 million in Revenue and $1.65 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.96.
In the last 3 years, INSP traded as high as $330.00 and as low as $53.11.
The top ETF exchange traded funds that INSP belongs to (by Net Assets): IJR, VTI, VB, VBK, VXF.
INSP has underperformed the market in the last year with a return of -64.0%, while the SPY ETF gained +18.7%. In the last 3 month period, INSP fell short of the market, returning -54.0%, while SPY returned -1.7%. However, in the most recent 2 weeks INSP has outperformed the stock market by returning +5.8%, while SPY returned -2.5%.
INSP support price is $59.39 and resistance is $65.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INSP shares will trade within this expected range on the day.